01Core principlesThe concepts and mechanisms needed to understand the subject.
MRI combines a powerful static magnetic field with switched gradients and radiofrequency energy. Hazards include projectile attraction, implant displacement or malfunction, tissue heating, peripheral nerve stimulation, acoustic injury, burns from conductive loops, and delayed rescue in a constrained environment.
MR safety labels have precise meanings. MR Safe items pose no known hazard in all MR environments; MR Unsafe items create unacceptable risk; MR Conditional items may enter only when every labelled condition such as field strength, spatial gradient, RF exposure, scan duration and patient position is met.
Gadolinium-based contrast agents are separate from iodinated contrast. Major considerations are indication, previous reaction, renal function when relevant, nephrogenic systemic fibrosis risk, pregnancy, breastfeeding, cumulative exposure and tissue retention whose clinical significance remains uncertain.
Key points
- MR Conditional means safe only when every stated condition is met for the exact device, scanner and protocol; it does not mean universally safe.
- Screen the patient, accompanying people and all equipment before each attendance, then resolve implants and foreign bodies before controlled-area access.
- In eGFR below 30 mL/min/1.73 m², use gadolinium only for compelling added value, choosing a lowest-NSF-risk macrocyclic agent at the smallest diagnostic dose.
- Avoid gadolinium in pregnancy unless essential information cannot be obtained adequately without it and benefit outweighs uncertain fetal risk.
- Breastfeeding can continue after routine gadolinium contrast under current RCR and SoR advice; nuclear medicine follows different rules.
- If an emergency develops, remove the patient from the MR environment before using ordinary resuscitation equipment.
02Mechanisms and patternsImportant relationships and how to distinguish them.
An item has no known hazard in all MR environments under its labelled use; verify the label rather than infer safety from appearance.
The exact device is acceptable only within stated field, gradient, RF, position, configuration and time limits that must be checked.
The item presents unacceptable risk in the MR environment and must not enter the restricted zone.
An incompletely identified implant is not presumed safe; use records, imaging, manufacturer data and the formal local safety procedure.
Sudden pain, heating, device symptoms, distress or physiological deterioration requires stopping acquisition and safely extracting the patient.
Nephrogenic systemic fibrosis is associated particularly with less stable gadolinium agents in severe renal dysfunction; risk varies by product.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Four-stage MR screening - Why
- Identify hazards from referral through final entry checks.
- Interpretation and limitations
- Repeat screening at each attendance and after transfers because devices, procedures, clothing or accompanying equipment may have changed.
- 02
Implant make and model - Why
- Link the patient device to authoritative safety labelling.
- Interpretation and limitations
- Confirm exact components and conditions; a generic device category or patient memory alone is insufficient for routine clearance.
- 03
Orbital or body imaging - Why
- Clarify possible ferromagnetic foreign material when history remains concerning.
- Interpretation and limitations
- Use the local MR safety pathway and appropriate prior imaging or focused radiography rather than exploratory magnet testing.
- 04
Renal function assessment - Why
- Identify severe renal impairment before selected gadolinium use.
- Interpretation and limitations
- For lowest-risk macrocyclic agents ESUR does not require eGFR universally, but known AKI or eGFR below 30 changes the benefit-risk decision.
- 05
Non-contrast MRI sequences - Why
- Determine whether the question can be answered without gadolinium.
- Interpretation and limitations
- Diffusion, susceptibility, flow and other sequences may provide sufficient information, but adequacy is indication-specific.
- 06
Contrast-enhanced MRI - Why
- Add vascularity, perfusion, barrier disruption or lesion characterisation when it changes care.
- Interpretation and limitations
- Administer only when incremental information is meaningful; in severe renal impairment, select a lowest-NSF-risk macrocyclic agent and use the smallest diagnostically adequate dose.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked caseMR Conditional cardiac deviceA patient presents with a device card but the planned scan conditions remain unverified.+
- 1Context: identify every generator, lead and component, the indication for MRI, dependency status and relevant device records.
- 2Reasoning: compare manufacturer conditions with scanner field strength, gradients, RF limits, anatomical restrictions and monitoring requirements.
- 3Outcome: scan only through the approved device pathway after programming and staffing requirements are satisfied, or choose an adequate alternative.
- 4Verification: document pre-scan checks, monitor as specified, restore device settings and complete post-scan assessment before discharge.
02Entry pathwayClear patient and equipmentAny person or item is proposed to enter an MR controlled area.+
- 1Complete trained screening and remove loose ferromagnetic objects, conductive loops, patches and unverified equipment.
- 2Resolve surgery, implants, foreign-body exposure, pregnancy and communication or monitoring needs.
- 3Apply the exact MR Safe or MR Conditional label and conditions to every necessary item.
- 4Maintain controlled access and repeat final checks immediately before entering the scanner room.
03Contrast decisionUse gadolinium proportionatelyThe proposed MRI may need intravenous gadolinium to answer the clinical question.+
- 1Confirm the incremental diagnostic value and whether non-contrast sequences or another test can answer adequately.
- 2Assess previous reaction, pregnancy and severe renal impairment, then select the agent through radiology protocols.
- 3For high NSF risk, use a lowest-risk macrocyclic agent only when benefit is compelling and keep dose minimal.
- 4Record product, dose and reaction details, and give appropriate aftercare and breastfeeding information.
04MR emergencyExtract and resuscitate safelyA patient becomes critically unwell in or near the magnet room.+
- 1Stop scanning, call the MR emergency response and remove the patient from the scanner bore promptly.
- 2Transfer to the designated safe resuscitation location before bringing ordinary emergency equipment near the magnet.
- 3Use only verified MR Safe or condition-compliant equipment if care must begin within the controlled environment.
- 4Treat the clinical emergency, preserve device and scan information, and review the MR safety event afterwards.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Document completion and outcome of screening at each attendance, including unresolved answers and the person authorising entry.
- For active implants, record programming, physiological monitoring and post-scan device checks required by the pathway.
- Observe patients for immediate contrast reactions and provide advice about delayed symptoms according to severity and local policy.
- Record the exact gadolinium product, administered dose, route and any extravasation or adverse event.
- Audit controlled-area breaches, projectile near misses, burns, hearing incidents and emergency extraction performance.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
The magnet stays on
Most clinical superconducting magnets remain energised continuously, so the scanner room is hazardous even when no images are being acquired.
Prior scanning proves little
A patient may previously have encountered another field strength, protocol or device configuration; repeat verification against today’s conditions is required.
Generic implant routes are governed
MHRA permits formal local procedures for defined low-risk implant groups, but they require documented evidence, scope and governance rather than ad hoc assumptions.
Pregnancy changes protocol
MHRA advises benefit-risk assessment, normal or standard operating mode, acoustic consideration and avoidance of gadolinium unless essential; local specialist input determines execution.
Retention remains uncertain
Gadolinium can be retained after all agent classes and more after linear agents, but current ESUR guidance reports no confirmed neurological syndrome from deposition.
Breastfeeding is distinct
Continued feeding after gadolinium contrast is supported by UK professional advice, while a maternal renal problem or radiopharmaceutical exposure needs separate assessment.
07Common pitfallsFrequent interpretation and management errors.
- 01
Reading MR Conditional as permission to scan without matching the exact device conditions to the planned examination.
- 02
Relying on a previous uneventful MRI as proof that an implant is safe today.
- 03
Taking ordinary oxygen cylinders, monitors or resuscitation trolleys into the magnet room during an emergency.
- 04
Treating gadolinium and iodinated contrast as interchangeable agents with identical renal and pregnancy advice.
- 05
Giving a higher-risk gadolinium agent in severe renal impairment without documenting compelling benefit and safer alternatives.